COVID-19: Is there a role for Western blots and skin testing for determining immunity and development of a vaccine?
Authors:
- Charles S. PaviaCPCharles S. Pavia
- Gary P. WormserGWGary P. Wormser
- 1 December 2020
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 98 (4) , 115148
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- COVID-19: Understanding the science of antibody testing and lessons from the HIV epidemicDiagnostic Microbiology and Infectious Disease, 2020
- Phenotype and kinetics of SARS-CoV-2–specific T cells in COVID-19 patients with acute respiratory distress syndromeScience Immunology, 2020
- Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS–CoV-2/COVID-19mBio, 2020
- Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives2020
- Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020Eurosurveillance, 2020
- Is COVID-19 receiving ADE from other coronaviruses?Microbes and Infection, 2020
- Antibody-dependent enhancement of severe dengue disease in humansScience, 2017
- Subversion of Innate Defenses by the Interplay between DENV and Pre-Existing Enhancing Antibodies: TLRs Signaling CollapsePLOS Neglected Tropical Diseases, 2010
- Plaque reduction neutralization test for human cytomegalovirus based upon enhanced uptake of neutral red by virus-infected cellsJournal of Clinical Microbiology, 1976
- PREVENTION OF CELL-TO-CELL SPREAD OF HERPES SIMPLEX VIRUS BY LEUKOCYTESJournal of Experimental Medicine, 1973